Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyResearch in context

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyResearch in context

Summary: Background: Cardiovascular disease incidence and mortality have declined across developed economies and granular up-to-date cost-effectiveness evidence is required for treatments targeting large populations. To assess the health benefits and cost-effectiveness of standard and higher intens...

Full description

Bibliographic Details
Main Authors: Borislava Mihaylova, Runguo Wu, Junwen Zhou, Claire Williams, Iryna Schlackow, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Richard Parnell, Jane Armitage, Alastair Gray, John Simes, Colin Baigent
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:The Lancet Regional Health. Europe
Subjects:
Cardiovascular diseases
Statin
Cost-effectiveness
Quality-adjusted life years
Health care costs
Microsimulation model
Online Access:http://www.sciencedirect.com/science/article/pii/S266677622400053X

Internet

http://www.sciencedirect.com/science/article/pii/S266677622400053X

Similar Items